SS Innovations International, Inc. has achieved a major milestone with the successful completion of the first robotic cardiac surgery in the Americas and the western hemisphere using the company's SSI Mantra 3 surgical robotic system. The surgery, performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador, involved a robotic atrial septal defect closure, a procedure that repairs a hole between the upper two chambers of the heart.
Dr. Zuniga noted that the experience with the SSI Mantra 3 system was positive, highlighting its ease of handling and manipulation, as well as the effective results in achieving a successful closure. He emphasized the benefits of minimally invasive procedures, citing faster recovery, reduced bleeding, and precise tissue manipulation and suturing with the robotic system.
Interhospital, which became the first hospital in South America to install the SSI Mantra, has utilized the surgical robotic system for a variety of complex surgical procedures since its installation.
The press release also provides a brief overview of SS Innovations International, Inc., which develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes the proprietary SSI Mantra surgical robotic system and its comprehensive suite of SSI Mudra surgical instruments, which support a variety of surgical procedures, including robotic cardiac surgery.
This press release does not include specific financial metrics or comparisons with previous periods. Today the company's shares have moved -9.23% to a price of $3.54. For the full picture, make sure to review SS Innovations International's 8-K report.
